Researchers have identified that G-quadruplexes promote harmful protein aggregation in neurodegenerative diseases. Blocking ...
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Anavex Life Sciences (AVXL – Research Report) today and set a price target of ...
The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer ... and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid ...
Acadia is on track to achieve over $1 billion in annualized sales in 2025. The next phase of growth could come from two ...
Earlier this month, I was also pleased to attend the 120th anniversary of the St. Nicholas Ukrainian Church at 6594 Henderson ...
Nuclear Medicine Market OverviewThe global nuclear medicine market is poised to experience substantial growth, projected to ...
Research unveils the complex relationship between dopamine and serotonin, transforming our understanding of brain chemistry ...
Hosted on MSN18h
This Sleep Occurrence May Indicate Your Risk Of DementiaPrevious research has discovered a possible link between distressing dreams and a higher risk of dementia in people with ...
Alector has significant cash reserves but faces high cash burn, with no immediate catalysts and uncertain prospects for its ...
News Medical on MSN3h
Study links combined risk factors for aggressive behavior in men with CTEPeople who have chronic traumatic encephalopathy (CTE) who have a family history of mental illness may have a higher risk of aggression in middle age, according to a study published in the November 27 ...
STOCKHOLM, SWEDEN / ACCESSWIRE / November 27, 2024 / (STO:ALZCUR)(FRA:AC6) AB (publ) (FN STO:ALZCUR), a pharmaceutical ...
Acadia signs a $610 million exclusive global license agreement with Saniona to develop and commercialize SAN711 for neurological disorder indications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback